Benefitfocus Announces Date of First Quarter 2022 Financial Results
Get Alerts BNFT Hot Sheet
Join SI Premium – FREE
CHARLESTON, S.C., April 18, 2022 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading cloud-based benefits administration technology company that simplifies benefits administration for employers, health plans and brokers, today announced it will report its first quarter 2022 results after U.S. financial markets close on Tuesday, May 3, 2022.
In conjunction with the company’s first quarter 2022 announcement, Benefitfocus will host a conference call to discuss the company’s financial results and business outlook on Tuesday, May 3, 2022, at 5:00 p.m. ET. To access this call, dial (877) 407-9208 (domestic) or +1 (201) 493-6784 (international). A live webcast of the conference call will be available on the Investor Relations page of the company’s website at http://investor.benefitfocus.com/. After the conference call, a replay will be available until May 10, 2022, and can be accessed by dialing (844) 512-2921 (domestic) or +1 (412) 317-6671 (international) with passcode 13729373.
About Benefitfocus
Benefitfocus (NASDAQ: BNFT) is a cloud-based benefits administration technology company committed to helping our customers, and the people they serve, get the most out of their health care and benefit programs. Through exceptional service and innovative SaaS solutions, we aim to be the safest set of hands for our customers helping to simplify the complexity of benefits administration while delivering an experience that engages people and unlocks the potential for better health and improved outcomes. Our mission is simple: to improve lives with benefits. Learn more at www.benefitfocus.com, LinkedIn, Facebook, Instagram and Twitter.
Source: Benefitfocus, Inc.
Benefitfocus, Inc.
843-981-8898
[email protected]
Investor Relations:
Doug Kuckelman
843-790-7460
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease
- Bitcoin Volatility Is Reshaping Crypto PR in 2026: Where BTCPressWire Fits
- Electrolit® Invites NYC Tennis Fans to Channel Their Inner Aryna Sabalenka at Saby's Slice Shop, with WTA World No. 1 Appearance
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share